Patching Strategies for Lazy Eye
(ATS22 Trial)
Trial Summary
What is the purpose of this trial?
A randomized trial to determine whether simultaneous treatment with spectacles and patching has an equivalent VA outcome compared with sequential treatment, first with spectacles alone followed by patching (if needed), for previously untreated amblyopia in children 3 to \<13 years of age.
Will I have to stop taking my current medications?
The trial protocol does not specify whether you need to stop taking your current medications. However, it does mention that participants must be willing to forego contact lens wear during the study.
What data supports the effectiveness of the treatment for lazy eye?
Research shows that patching, which involves covering the stronger eye to improve the weaker one, is a traditional and effective treatment for lazy eye. Studies have explored different methods to improve compliance, such as over-glasses patching and using video games, indicating that these approaches can also be effective in improving vision in children with amblyopia.12345
How does the patching treatment for lazy eye differ from other treatments?
The patching treatment for lazy eye is unique because it involves covering one eye with a patch to improve the weaker eye's vision, often combined with wearing glasses. This approach is different from other treatments like penalization, which uses eye drops to blur vision in the stronger eye, encouraging use of the weaker eye.35678
Research Team
Vivian Manh
Principal Investigator
Seattle Children's Hospital, University of Washington
Michael Gray
Principal Investigator
Children's Hospital Medical Center, Cincinnati
Eligibility Criteria
This trial is for children aged 3 to under 13 with lazy eye (amblyopia) who haven't been treated before. It's open to those with a certain type of misalignment in their eyes (strabismus), a difference in prescription between the eyes, or both. Kids can't join if they have severe nearsightedness, previous eye surgery, allergies to silicone or adhesive patches, or developmental delays that could affect treatment.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline
Participants are prescribed spectacles and return for a baseline visit to confirm eligibility before randomization
Treatment
Participants receive either sequential or simultaneous treatment with spectacles and patching, with follow-up visits every 8 weeks
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Glasses (Procedure)
- Patching (Behavioural Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Jaeb Center for Health Research
Lead Sponsor
National Eye Institute (NEI)
Collaborator
Pediatric Eye Disease Investigator Group
Collaborator